Spotlight On TSX Penny Stocks For October 2024

In This Article:

Over the last 7 days, the Canadian market has risen by 1.0%, and over the past year, it is up by an impressive 27%. Investing in penny stocks—though a somewhat outdated term—can still provide access to growth opportunities, especially in smaller or newer companies. These stocks can offer significant value when backed by strong financial health, and we'll explore several that might pair balance sheet strength with long-term potential.

Top 10 Penny Stocks In Canada

Name

Share Price

Market Cap

Financial Health Rating

PetroTal (TSX:TAL)

CA$0.67

CA$620.84M

★★★★★★

Findev (TSXV:FDI)

CA$0.42

CA$11.75M

★★★★★☆

Winshear Gold (TSXV:WINS)

CA$0.18

CA$4.4M

★★★★★★

Mandalay Resources (TSX:MND)

CA$3.34

CA$304.56M

★★★★★★

Pulse Seismic (TSX:PSD)

CA$2.37

CA$119.71M

★★★★★★

Amerigo Resources (TSX:ARG)

CA$1.80

CA$298.44M

★★★★★☆

Foraco International (TSX:FAR)

CA$2.37

CA$236.62M

★★★★★☆

East West Petroleum (TSXV:EW)

CA$0.04

CA$3.17M

★★★★★★

Newport Exploration (TSXV:NWX)

CA$0.115

CA$12.14M

★★★★★★

NamSys (TSXV:CTZ)

CA$1.11

CA$29.82M

★★★★★★

Click here to see the full list of 948 stocks from our TSX Penny Stocks screener.

Let's dive into some prime choices out of the screener.

Cronos Group

Simply Wall St Financial Health Rating: ★★★★★★

Overview: Cronos Group Inc. is a cannabinoid company involved in the cultivation, production, and marketing of cannabis products in Canada, Israel, and Germany with a market cap of CA$1.14 billion.

Operations: The company generates revenue of $101.78 million from its operations in the cultivation, manufacture, and marketing of cannabis and cannabis-derived products.

Market Cap: CA$1.14B

Cronos Group Inc. is navigating the volatile penny stock landscape with a focus on expanding its premium cannabis product offerings under the Lord Jones brand, recently introducing new cultivars and vape products in Canada. Despite generating CA$1.14 billion in market cap and US$101.78 million in revenue, Cronos remains unprofitable, reporting a net loss of US$11 million for the first half of 2024. The company benefits from a strong asset position with short-term assets significantly exceeding liabilities and operates debt-free, but faces challenges such as an inexperienced board and ongoing profitability issues amidst industry competition.

TSX:CRON Financial Position Analysis as at Oct 2024
TSX:CRON Financial Position Analysis as at Oct 2024

Mandalay Resources

Simply Wall St Financial Health Rating: ★★★★★★

Overview: Mandalay Resources Corporation, with a market cap of CA$304.56 million, is involved in the acquisition, exploration, extraction, processing, and reclamation of mineral properties across Canada, Australia, Sweden, and Chile.